|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.71 USD | +2.96% |
|
-0.30% | -22.35% |
| 03-04 | NervGen Pharma Corp. Announces Executive Changes | CI |
| 03-03 | Sarepta Therapeutics, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 01:50 PM |
| Capitalization | 1.75B 1.51B 1.37B 1.31B 2.39B 161B 2.5B 16.14B 6.47B 77.32B 6.58B 6.44B 277B | P/E ratio 2026 * |
5.31x | P/E ratio 2027 * | 13.3x |
|---|---|---|---|---|---|
| Enterprise value | 1.29B 1.11B 1.01B 965M 1.76B 119B 1.84B 11.89B 4.76B 56.94B 4.85B 4.75B 204B | EV / Sales 2026 * |
0.75x | EV / Sales 2027 * | 0.7x |
| Free-Float |
95.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sarepta Therapeutics, Inc.
| 1 day | +2.96% | ||
| 1 week | -0.30% | ||
| Current month | -0.30% | ||
| 1 month | -9.68% | ||
| 3 months | -23.56% | ||
| 6 months | -5.06% | ||
| Current year | -22.35% |
| 1 week | 15.52 |  | 16.88 |
| 1 month | 15.52 | | 19.25 |
| Current year | 15.52 | | 24.68 |
| 1 year | 10.42 | | 103.32 |
| 3 years | 10.42 | | 173.25 |
| 5 years | 10.42 | | 173.25 |
| 10 years | 8 | | 181.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 63 | 25/06/2017 |
Ryan Wong
DFI | Director of Finance/CFO | 47 | 15/07/2025 |
Ian Estepan
DFI | Director of Finance/CFO | 50 | 13/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
M. Wilsey
CHM | Chairman | 73 | 15/04/2015 |
| Director/Board Member | 87 | 31/05/2010 | |
Richard Barry
BRD | Director/Board Member | 67 | 01/06/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 4.63% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.96% | -0.30% | -83.78% | -89.08% | 1.75B | |
| -0.98% | -9.15% | -44.98% | -49.99% | 2.05B | |
| -0.73% | -2.85% | +12.35% | -25.21% | 373M | |
| -1.25% | -5.08% | -27.77% | - | 76.46M | |
| Average | 0.00% | -4.35% | -36.05% | -54.76% | 1.06B | |
| Weighted average by Cap. | +0.66% | -4.87% | -55.65% | -64.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.73B 1.49B 1.34B 1.29B 2.35B 159B 2.46B 15.89B 6.37B 76.11B 6.48B 6.34B 272B | 1.45B 1.25B 1.13B 1.08B 1.97B 133B 2.06B 13.3B 5.33B 63.7B 5.43B 5.31B 228B |
| Net income | 345M 297M 269M 258M 470M 31.71B 492M 3.17B 1.27B 15.21B 1.29B 1.27B 54.38B | 109M 93.81M 84.68M 81.25M 148M 10B 155M 1B 401M 4.8B 408M 400M 17.15B |
| Net Debt | -462M -399M -360M -345M -630M -42.5B -659M -4.25B -1.7B -20.38B -1.74B -1.7B -72.89B | -742M -640M -578M -554M -1.01B -68.19B -1.06B -6.83B -2.74B -32.7B -2.78B -2.73B -117B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 16.71 $ | +2.96% | 3,069,287 |
| 05/03/26 | 16.23 $ | +0.87% | 2,486,480 |
| 04/03/26 | 16.09 $ | +1.39% | 2,072,962 |
| 03/03/26 | 15.87 $ | -2.76% | 2,015,676 |
| 02/03/26 | 16.32 $ | -2.63% | 2,510,243 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SRPT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition